English
简体中文
Total: £ 56.28
Published Date: 2026-04-02 | Pages: 113 | Tables: 111 | Pharma & Healthcare
The global Cattle Vaccine market was valued at US$ 1780 million in 2025 and is anticipated to reach US$ 2723 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
A cattle vaccine is a biological preparation designed to help cattle (both beef and dairy) develop immunity against specific infectious diseases.
It contains weakened, killed, or inactivated pathogens (or parts of them, such as proteins or toxins) that stimulate the cow’s immune system to recognize and fight the disease without causing the disease itself. In 2024, global cattle vaccines production reached approximately 160 million units , with an average global market price of around US$ 10.5 per unit.
Global outbreaks of infectious bovine diseases—such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex (BRDC), Brucellosis, and Bovine Viral Diarrhea (BVD)—are increasing vaccination adoption rates. These diseases can cause massive productivity and economic losses in the livestock industry, making preventive vaccination an essential part of herd management.
Increasing demand for high-quality beef and dairy products, especially in Asia-Pacific and Latin America, is pushing farmers to invest in vaccines to maintain herd productivity and product safety.
Many regions (e.g., EU, parts of South America, India) implement government-subsidized or mandatory cattle vaccination programs to control endemic diseases, ensuring market stability.
Development of recombinant DNA vaccines, subunit vaccines, and mRNA-based veterinary vaccines is accelerating, improving efficacy and reducing adverse reactions.
Multi-disease vaccines are gaining popularity for reducing labor costs and stress on animals during administration.
Especially important for developing countries, thermostable vaccines reduce dependency on cold chain logistics.
This report delivers a comprehensive overview of the global Cattle Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cattle Vaccine. The Cattle Vaccine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cattle Vaccine market comprehensively. Regional market sizes by Type, by Sales Channel, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cattle Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.
Market Segmentation
By Company
Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Zoetis
Elanco Animal Health
Indian Immunologicals
Cambridge Technologies
Vaxxinova
Jinyu Bio-Technolog
China Animal Husbandry Industry
Tecon Biology
Segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Others
Segment by Sales Channel
Government Bidding
Market Sales
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cattle Vaccine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Sales Channel, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cattle Vaccine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Live Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.2.4 Others
1.3 Market by Sales Channel
1.3.1 Global Cattle Vaccine Market Growth by Sales Channel: 2021 vs 2025 vs 2032
1.3.2 Government Bidding
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cattle Vaccine Market Perspective (2021–2032)
2.2 Global Cattle Vaccine Growth Trends by Region
2.2.1 Global Cattle Vaccine Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cattle Vaccine Historic Market Size by Region (2021–2026)
2.2.3 Cattle Vaccine Forecasted Market Size by Region (2027–2032)
2.3 Cattle Vaccine Market Dynamics
2.3.1 Cattle Vaccine Industry Trends
2.3.2 Cattle Vaccine Market Drivers
2.3.3 Cattle Vaccine Market Challenges
2.3.4 Cattle Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cattle Vaccine Players by Revenue
3.1.1 Global Top Cattle Vaccine Players by Revenue (2021–2026)
3.1.2 Global Cattle Vaccine Revenue Market Share by Players (2021–2026)
3.2 Global Top Cattle Vaccine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cattle Vaccine Revenue
3.4 Global Cattle Vaccine Market Concentration Ratio
3.4.1 Global Cattle Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cattle Vaccine Revenue in 2025
3.5 Global Key Players of Cattle Vaccine Head Offices and Areas Served
3.6 Global Key Players of Cattle Vaccine, Products and Applications
3.7 Global Key Players of Cattle Vaccine, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cattle Vaccine Breakdown Data by Type
4.1 Global Cattle Vaccine Historic Market Size by Type (2021–2026)
4.2 Global Cattle Vaccine Forecasted Market Size by Type (2027–2032)
5 Cattle Vaccine Breakdown Data by Sales Channel
5.1 Global Cattle Vaccine Historic Market Size by Sales Channel (2021–2026)
5.2 Global Cattle Vaccine Forecasted Market Size by Sales Channel (2027–2032)
6 North America
6.1 North America Cattle Vaccine Market Size (2021–2032)
6.2 North America Cattle Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cattle Vaccine Market Size by Country (2021–2026)
6.4 North America Cattle Vaccine Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cattle Vaccine Market Size (2021–2032)
7.2 Europe Cattle Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cattle Vaccine Market Size by Country (2021–2026)
7.4 Europe Cattle Vaccine Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cattle Vaccine Market Size (2021–2032)
8.2 Asia-Pacific Cattle Vaccine Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cattle Vaccine Market Size by Region (2021–2026)
8.4 Asia-Pacific Cattle Vaccine Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cattle Vaccine Market Size (2021–2032)
9.2 Latin America Cattle Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cattle Vaccine Market Size by Country (2021–2026)
9.4 Latin America Cattle Vaccine Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cattle Vaccine Market Size (2021–2032)
10.2 Middle East & Africa Cattle Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cattle Vaccine Market Size by Country (2021–2026)
10.4 Middle East & Africa Cattle Vaccine Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Cattle Vaccine Introduction
11.1.4 Merck Animal Health Revenue in Cattle Vaccine Business (2021–2026)
11.1.5 Merck Animal Health Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Details
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Cattle Vaccine Introduction
11.2.4 Zoetis Revenue in Cattle Vaccine Business (2021–2026)
11.2.5 Zoetis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Cattle Vaccine Introduction
11.3.4 Boehringer Ingelheim Revenue in Cattle Vaccine Business (2021–2026)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Ceva
11.4.1 Ceva Company Details
11.4.2 Ceva Business Overview
11.4.3 Ceva Cattle Vaccine Introduction
11.4.4 Ceva Revenue in Cattle Vaccine Business (2021–2026)
11.4.5 Ceva Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Cattle Vaccine Introduction
11.5.4 Zoetis Revenue in Cattle Vaccine Business (2021–2026)
11.5.5 Zoetis Recent Development
11.6 Elanco Animal Health
11.6.1 Elanco Animal Health Company Details
11.6.2 Elanco Animal Health Business Overview
11.6.3 Elanco Animal Health Cattle Vaccine Introduction
11.6.4 Elanco Animal Health Revenue in Cattle Vaccine Business (2021–2026)
11.6.5 Elanco Animal Health Recent Development
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Details
11.7.2 Indian Immunologicals Business Overview
11.7.3 Indian Immunologicals Cattle Vaccine Introduction
11.7.4 Indian Immunologicals Revenue in Cattle Vaccine Business (2021–2026)
11.7.5 Indian Immunologicals Recent Development
11.8 Cambridge Technologies
11.8.1 Cambridge Technologies Company Details
11.8.2 Cambridge Technologies Business Overview
11.8.3 Cambridge Technologies Cattle Vaccine Introduction
11.8.4 Cambridge Technologies Revenue in Cattle Vaccine Business (2021–2026)
11.8.5 Cambridge Technologies Recent Development
11.9 Vaxxinova
11.9.1 Vaxxinova Company Details
11.9.2 Vaxxinova Business Overview
11.9.3 Vaxxinova Cattle Vaccine Introduction
11.9.4 Vaxxinova Revenue in Cattle Vaccine Business (2021–2026)
11.9.5 Vaxxinova Recent Development
11.10 Jinyu Bio-Technolog
11.10.1 Jinyu Bio-Technolog Company Details
11.10.2 Jinyu Bio-Technolog Business Overview
11.10.3 Jinyu Bio-Technolog Cattle Vaccine Introduction
11.10.4 Jinyu Bio-Technolog Revenue in Cattle Vaccine Business (2021–2026)
11.10.5 Jinyu Bio-Technolog Recent Development
11.11 China Animal Husbandry Industry
11.11.1 China Animal Husbandry Industry Company Details
11.11.2 China Animal Husbandry Industry Business Overview
11.11.3 China Animal Husbandry Industry Cattle Vaccine Introduction
11.11.4 China Animal Husbandry Industry Revenue in Cattle Vaccine Business (2021–2026)
11.11.5 China Animal Husbandry Industry Recent Development
11.12 Tecon Biology
11.12.1 Tecon Biology Company Details
11.12.2 Tecon Biology Business Overview
11.12.3 Tecon Biology Cattle Vaccine Introduction
11.12.4 Tecon Biology Revenue in Cattle Vaccine Business (2021–2026)
11.12.5 Tecon Biology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cattle Vaccine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Live Attenuated Vaccine
Table 3. Key Players of Inactivated Vaccine
Table 4. Key Players of Others
Table 5. Global Cattle Vaccine Market Size Growth by Sales Channel (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cattle Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Cattle Vaccine Market Size by Region (US$ Million), 2021–2026
Table 8. Global Cattle Vaccine Market Share by Region (2021–2026)
Table 9. Global Cattle Vaccine Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Cattle Vaccine Market Share by Region (2027–2032)
Table 11. Cattle Vaccine Market Trends
Table 12. Cattle Vaccine Market Drivers
Table 13. Cattle Vaccine Market Challenges
Table 14. Cattle Vaccine Market Restraints
Table 15. Global Cattle Vaccine Revenue by Players (US$ Million), 2021–2026
Table 16. Global Cattle Vaccine Market Share by Players (2021–2026)
Table 17. Global Top Cattle Vaccine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cattle Vaccine Revenue, 2025
Table 18. Ranking of Global Top Cattle Vaccine Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Cattle Vaccine Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Cattle Vaccine, Headquarters and Area Served
Table 21. Global Key Players of Cattle Vaccine, Products and Applications
Table 22. Global Key Players of Cattle Vaccine, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Cattle Vaccine Market Size by Type (US$ Million), 2021–2026
Table 25. Global Cattle Vaccine Revenue Market Share by Type (2021–2026)
Table 26. Global Cattle Vaccine Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Cattle Vaccine Revenue Market Share by Type (2027–2032)
Table 28. Global Cattle Vaccine Market Size by Sales Channel (US$ Million), 2021–2026
Table 29. Global Cattle Vaccine Revenue Market Share by Sales Channel (2021–2026)
Table 30. Global Cattle Vaccine Forecasted Market Size by Sales Channel (US$ Million), 2027–2032
Table 31. Global Cattle Vaccine Revenue Market Share by Sales Channel (2027–2032)
Table 32. North America Cattle Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Cattle Vaccine Market Size by Country (US$ Million), 2021–2026
Table 34. North America Cattle Vaccine Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Cattle Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Cattle Vaccine Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Cattle Vaccine Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Cattle Vaccine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Cattle Vaccine Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Cattle Vaccine Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Cattle Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Cattle Vaccine Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Cattle Vaccine Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Cattle Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Cattle Vaccine Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Cattle Vaccine Market Size by Country (US$ Million), 2027–2032
Table 47. Merck Animal Health Company Details
Table 48. Merck Animal Health Business Overview
Table 49. Merck Animal Health Cattle Vaccine Product
Table 50. Merck Animal Health Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 51. Merck Animal Health Recent Development
Table 52. Zoetis Company Details
Table 53. Zoetis Business Overview
Table 54. Zoetis Cattle Vaccine Product
Table 55. Zoetis Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 56. Zoetis Recent Development
Table 57. Boehringer Ingelheim Company Details
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Cattle Vaccine Product
Table 60. Boehringer Ingelheim Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 61. Boehringer Ingelheim Recent Development
Table 62. Ceva Company Details
Table 63. Ceva Business Overview
Table 64. Ceva Cattle Vaccine Product
Table 65. Ceva Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 66. Ceva Recent Development
Table 67. Zoetis Company Details
Table 68. Zoetis Business Overview
Table 69. Zoetis Cattle Vaccine Product
Table 70. Zoetis Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 71. Zoetis Recent Development
Table 72. Elanco Animal Health Company Details
Table 73. Elanco Animal Health Business Overview
Table 74. Elanco Animal Health Cattle Vaccine Product
Table 75. Elanco Animal Health Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 76. Elanco Animal Health Recent Development
Table 77. Indian Immunologicals Company Details
Table 78. Indian Immunologicals Business Overview
Table 79. Indian Immunologicals Cattle Vaccine Product
Table 80. Indian Immunologicals Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 81. Indian Immunologicals Recent Development
Table 82. Cambridge Technologies Company Details
Table 83. Cambridge Technologies Business Overview
Table 84. Cambridge Technologies Cattle Vaccine Product
Table 85. Cambridge Technologies Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 86. Cambridge Technologies Recent Development
Table 87. Vaxxinova Company Details
Table 88. Vaxxinova Business Overview
Table 89. Vaxxinova Cattle Vaccine Product
Table 90. Vaxxinova Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 91. Vaxxinova Recent Development
Table 92. Jinyu Bio-Technolog Company Details
Table 93. Jinyu Bio-Technolog Business Overview
Table 94. Jinyu Bio-Technolog Cattle Vaccine Product
Table 95. Jinyu Bio-Technolog Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 96. Jinyu Bio-Technolog Recent Development
Table 97. China Animal Husbandry Industry Company Details
Table 98. China Animal Husbandry Industry Business Overview
Table 99. China Animal Husbandry Industry Cattle Vaccine Product
Table 100. China Animal Husbandry Industry Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 101. China Animal Husbandry Industry Recent Development
Table 102. Tecon Biology Company Details
Table 103. Tecon Biology Business Overview
Table 104. Tecon Biology Cattle Vaccine Product
Table 105. Tecon Biology Revenue in Cattle Vaccine Business (US$ Million), 2021–2026
Table 106. Tecon Biology Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Cattle Vaccine Picture
Figure 2. Global Cattle Vaccine Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cattle Vaccine Market Share by Type: 2025 vs 2032
Figure 4. Live Attenuated Vaccine Features
Figure 5. Inactivated Vaccine Features
Figure 6. Others Features
Figure 7. Global Cattle Vaccine Market Size by Sales Channel (US$ Million), 2021–2032
Figure 8. Global Cattle Vaccine Market Share by Sales Channel: 2025 vs 2032
Figure 9. Government Bidding Case Studies
Figure 10. Market Sales Case Studies
Figure 11. Cattle Vaccine Report Years Considered
Figure 12. Global Cattle Vaccine Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Cattle Vaccine Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Cattle Vaccine Market Share by Region: 2025 vs 2032
Figure 15. Global Cattle Vaccine Market Share by Players in 2025
Figure 16. Global Cattle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Cattle Vaccine Revenue in 2025
Figure 18. North America Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Cattle Vaccine Market Share by Country (2021–2032)
Figure 20. United States Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Cattle Vaccine Market Share by Country (2021–2032)
Figure 24. Germany Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Cattle Vaccine Market Share by Region (2021–2032)
Figure 32. China Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Cattle Vaccine Market Share by Country (2021–2032)
Figure 40. Mexico Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Cattle Vaccine Market Share by Country (2021–2032)
Figure 44. Israel Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Cattle Vaccine Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Merck Animal Health Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 48. Zoetis Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 50. Ceva Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 51. Zoetis Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 52. Elanco Animal Health Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 53. Indian Immunologicals Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 54. Cambridge Technologies Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 55. Vaxxinova Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 56. Jinyu Bio-Technolog Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 57. China Animal Husbandry Industry Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 58. Tecon Biology Revenue Growth Rate in Cattle Vaccine Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
